Y Wang
United States Food and Drug Administration · 8 works · 794 citations · h-index 8
Top works
- Elucidation of Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug Development
- Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006
- Association of Time‐Varying Clearance of Nivolumab With Disease Dynamics and Its Implications on Exposure Response Analysis
- Exposure–Response Relationship of T-DM1: Insight Into Dose Optimization for Patients With HER2-Positive Metastatic Breast Cancer
- The Liver Toxicity Knowledge Base: A Systems Approach to a Complex End Point
- Toward Greater Insights on Pharmacokinetics and Exposure–Response Relationships for Therapeutic Biologics in Oncology Drug Development
- Operational Characteristics of Linear Concentration‐QT Models for Assessing QTc Interval in the Thorough QT and Phase I Clinical Studies
- Justification of noninferiority margin: Methodology considerations in an exposure–response analysis